figshare: https://api.figshare.com/v2/articles/28823159
version: 2.1.0
datasets:
  beataml:
    description: Beat acute myeloid leukemia (BeatAML) focuses on acute myeloid leukemia
      tumor data. Data includes drug response, proteomics, and transcriptomics datasets.
    references:
    - citation: Bottomly D, Long N, Schultz AR, et al. Integrative analysis of drug
        response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022;40(8):850-864.e9.
      doi: https://doi.org/10.1016/j.ccell.2022.07.002
    - citation: Pino JC, Posso C, Joshi SK, et al. Mapping the proteogenomic landscape
        enables prediction of drug response in acute myeloid leukemia. Cell Rep Med.
        2024;5(1):101359.
      doi: https://doi.org/10.1016/j.xcrm.2023.101359
    modalities:
      - sample
      - transcriptomics
      - mutations
      - proteomics
      - drug
      - drug descriptor
      - experiments

  bladderpdo:
    description: Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
      Data includes transcriptomics, mutations, copy number, and drug response data.
    references:
    - citation: Suk Hyung Lee, Wenhuo Hu, Justin T. Matulay, Mark V. Silva, 
        Tomasz B. Owczarek, Kwanghee Kim, Chee Wai Chua, LaMont J. Barlow, 
        Cyriac Kandoth, Alanna B. Williams, Sarah K. Bergren, Eugene J. Pietzak, 
        Christopher B. Anderson, Mitchell C. Benson, Jonathan A. Coleman, Barry S. Taylor, 
        Cory Abate-Shen, James M. McKiernan, Hikmat Al-Ahmadie, David B. Solit, Michael M. Shen.
        Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
        Cell. 2018;173(2):515-528.e17.
      doi: https://doi.org/10.1016/j.cell.2018.03.017
    modalities:
      - sample
      - transcriptomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  ccle:
    description: Cancer Cell Line Encyclopedia (CCLE).
    references:
    - citation: Barretina J, Caponigro G, Stransky N, et al. The Cancer Cell Line
        Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature.
        2012;483(7391):603-607. Published 2012 Mar 28.
      doi: https://doi.org/10.1038/nature11003
    modalities:
      - sample
      - transcriptomics
      - proteomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  cptac:
    description: The Clinical Proteomic Tumor Analysis Consortium (CPTAC) project
      is a collaborative network funded by the National Cancer Institute (NCI) focused
      on improving our understanding of cancer biology through the integration of
      transcriptomic, proteomic, and genomic data.
    references:
    - citation: Lindgren CM, Adams DW, Kimball B, et al. Simplified and Unified Access
        to Cancer Proteogenomic Data. J Proteome Res. 2021;20(4):1902-1910.
      doi: doi:10.1021/acs.jproteome.0c00919
    modalities:
      - sample
      - transcriptomics
      - proteomics
      - mutations
      - copy number

  ctrpv2:
    description: Cancer Therapeutics Response Portal version 2 (CTRPv2)
    references:
    - citation: Rees MG, Seashore-Ludlow B, Cheah JH, et al. Correlating chemical
        sensitivity and basal gene expression reveals mechanism of action. Nat Chem
        Biol. 2016;12(2):109-116.
      doi: doi:10.1038/nchembio.1986
    - citation: Seashore-Ludlow B, Rees MG, Cheah JH, et al. Harnessing Connectivity
        in a Large-Scale Small-Molecule Sensitivity Dataset. Cancer Discov. 2015;5(11):1210-1223.
      doi: doi:10.1158/2159-8290.CD-15-0235
    - citation: Basu A, Bodycombe NE, Cheah JH, et al. An interactive resource to
        identify cancer genetic and lineage dependencies targeted by small molecules.
        Cell. 2013;154(5):1151-1161.
      doi: doi:10.1016/j.cell.2013.08.003
    modalities:
      - sample
      - transcriptomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  fimm:
    description: Institute for Molecular Medicine Finland (FIMM) dataset.
    references:
    - citation: "Mpindi JP, Yadav B, \xD6stling P, et al. Consistency in drug response\
        \ profiling. Nature. 2016;540(7631):E5-E6."
      doi: doi:10.1038/nature20171
    - citation: Pemovska T, Kontro M, Yadav B, et al. Individualized systems medicine
        strategy to tailor treatments for patients with chemorefractory acute myeloid
        leukemia. Cancer Discov. 2013;3(12):1416-1429.
      doi: doi:10.1158/2159-8290.CD-13-0350
    modalities:
      - sample
      - transcriptomics
      - drug
      - drug descriptor
      - experiments

  gcsi:
    description: The Genentech Cell Line Screening Initiative (gCSI)
    references:
    - citation: Haverty PM, Lin E, Tan J, et al. Reproducible pharmacogenomic profiling
        of cancer cell line panels. Nature. 2016;533(7603):333-337.
      doi: https://doi.org/10.1038/nature17987
    - citation: Klijn C, Durinck S, Stawiski EW, et al. A comprehensive transcriptional
        portrait of human cancer cell lines. Nat Biotechnol. 2015;33(3):306-312.
      doi: https://doi.org/10.1038/nbt.3080
    modalities:
      - sample
      - transcriptomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  gdscv1:
    description: Genomics of Drug Sensitivity in Cancer (GDSC) v1
    references:
    - citation: Garnett MJ, Edelman EJ, Heidorn SJ, et al. Systematic identification
        of genomic markers of drug sensitivity in cancer cells. Nature. 2012;483(7391):570-575.
        Published 2012 Mar 28.
      doi: doi:10.1038/nature11005
    - citation: Iorio F, Knijnenburg TA, Vis DJ, et al. A Landscape of Pharmacogenomic
        Interactions in Cancer. Cell. 2016;166(3):740-754.
      doi: doi:10.1016/j.cell.2016.06.017
    - citation: 'Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity
        in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer
        cells. Nucleic Acids Res. 2013;41(Database issue):D955-D961.'
      doi: doi:10.1093/nar/gks1111
    modalities:
      - sample
      - transcriptomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  gdscv2:
    description: Genomics of Drug Sensitivity in Cancer (GDSC) v2
    references:
    - citation: Garnett MJ, Edelman EJ, Heidorn SJ, et al. Systematic identification
        of genomic markers of drug sensitivity in cancer cells. Nature. 2012;483(7391):570-575.
        Published 2012 Mar 28.
      doi: doi:10.1038/nature11005
    - citation: Iorio F, Knijnenburg TA, Vis DJ, et al. A Landscape of Pharmacogenomic
        Interactions in Cancer. Cell. 2016;166(3):740-754.
      doi: doi:10.1016/j.cell.2016.06.017
    - citation: 'Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity
        in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer
        cells. Nucleic Acids Res. 2013;41(Database issue):D955-D961.'
      doi: doi:10.1093/nar/gks1111
    modalities:
      - sample
      - transcriptomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  hcmi:
    description: Human Cancer Models Initiative (HCMI) encompasses numerous cancer
      types and includes cell line, organoid, and tumor data. Data includes the transcriptomics,
      somatic mutation, and copy number datasets.
    modalities:
      - sample
      - transcriptomics
      - mutations
      - copy number

  mpnst:
    description: Malignant Peripheral Nerve Sheath Tumor is a rare, agressive sarcoma
      that affects peripheral nerves throughout the body.
    references:
    - citation: Dehner C, Moon CI, Zhang X, et al. Chromosome 8 gain is associated
        with high-grade transformation in MPNST. JCI Insight. 2021;6(6):e146351. Published
        2021 Mar 22.
      doi: https://doi.org/10.1172/jci.insight.146351
    modalities:
      - sample
      - transcriptomics
      - proteomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  mpnstpdx:
    description: Patient derived xenograft data for MPNST
    modalities:
      - sample
      - transcriptomics
      - drug
      - drug descriptor
      - experiments

  nci60:
    description: National Cancer Institute 60
    references:
    - citation: Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen.
        Nat Rev Cancer. 2006;6(10):813-823.
      doi: doi:10.1038/nrc1951
    modalities:
      - sample
      - transcriptomics
      - mutations
      - proteomics
      - drug
      - drug descriptor
      - experiments

  pancpdo:
    description: Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
      Data includes transcriptomics, mutations, copy number, and drug response data.
    references:
    - citation: Hervé Tiriac, Pascal Belleau, Dannielle D. Engle, Dennis Plenker, Astrid Deschênes, 
        Tim D. D. Somerville, Fieke E. M. Froeling, Richard A. Burkhart, Robert E. Denroche, Gun-Ho Jang,
        Koji Miyabayashi, C. Megan Young, Hardik Patel, Michelle Ma, Joseph F. LaComb, Randze L. D. Palmaira, 
        Ammar A. Javed, Jasmine C. Huynh, Molly Johnson, Kanika Arora, Nicolas Robine, Minita Shah, 
        Rashesh Sanghvi, Austin B. Goetz, Cinthya Y. Lowder, Laura Martello, Else Driehuis, Nicolas LeComte, 
        Gokce Askan, Christine A. Iacobuzio-Donahue, Hans Clevers, Laura D. Wood, Ralph H. Hruban, Elizabeth Thompson,
        Andrew J. Aguirre, Brian M. Wolpin, Aaron Sasson, Joseph Kim, Maoxin Wu, Juan C. Bucobo, Peter Allen, 
        Divyesh V. Sejpal, William Nealon, James D. Sullivan, Jordan M. Winter, Phyllis A. Gimotty, Jean L. Grem, 
        Dominick J. DiMaio, Jonathan M. Buscaglia, Paul M. Grandgenett, Jonathan R. Brody, Michael A. Hollingsworth, 
        Grainne M. O’Kane, Faiyaz Notta, Edward Kim, James M. Crawford, Craig Devoe, Allyson Ocean, Christopher L. Wolfgang, 
        Kenneth H. Yu, Ellen Li, Christopher R. Vakoc, Benjamin Hubert, Sandra E. Fischer, Julie M. Wilson, Richard Moffitt, 
        Jennifer Knox, Alexander Krasnitz, Steven Gallinger, David A. Tuveson. Organoid Profiling Identifies Common 
        Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018;8(9):1112-1129.
      doi: https://doi.org/10.1158/2159-8290.CD-18-0349
    modalities:
      - sample
      - transcriptomics
      - mutations
      - copy number
      - drug
      - drug descriptor
      - experiments

  prism:
    description: Profiling Relative Inhibition Simultaneously in Mixtures
    references:
    - citation: Corsello SM, Nagari RT, Spangler RD, et al. Discovering the anti-cancer
        potential of non-oncology drugs by systematic viability profiling. Nat Cancer.
        2020;1(2):235-248.
      doi: doi:10.1038/s43018-019-0018-6
    - citation: Yu C, Mannan AM, Yvone GM, et al. High-throughput identification of
        genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell
        lines. Nat Biotechnol. 2016;34(4):419-423.
      doi: doi:10.1038/nbt.3460
    modalities:
      - sample
      - transcriptomics
      - drug
      - drug descriptor
      - experiments

  sarcpdo:
    description: The landscape of drug sensitivity and resistance in sarcoma
      Data includes transcriptomics, mutations, and drug response data.
    references:
    - citation: Ahmad Al Shihabi, Peyton J. Tebon, Huyen T. L. Nguyen,
        Jomjit Chantharasamee, Sara Sartini, Ardalan Davarifar, Alexandra Y. Jensen,
        Miranda Diaz-Infante, Hannah Cox, Alfredo E. Gonzalez, Summer Norris, Jantzen Sperry,
        Jonathan Nakashima, Nasrin Tavanaie, Helena Winata, Sorel T. Fitz-Gibbon,
        Takafumi N. Yamaguchi, Jae H. Jeong, Sarah Dry, Arun S. Singh, Bartosz Chmielowski,
        Joseph G. Crompton, Anusha K. Kalbasi, Fritz C. Eilber, Francis Hornicek,
        Nicholas M. Bernthal, Scott D. Nelson, Paul C. Boutros, Noah C. Federman, Jane Yanagawa,
        Alice Soragni. The landscape of drug sensitivity and resistance in sarcoma.
        Cell Stem Cell. 2024;31(10):1524-1542.e4.
      doi: https://doi.org/10.1016/j.stem.2024.08.010
    modalities:
      - sample
      - transcriptomics
      - mutations
      - drug
      - drug descriptor
      - experiments
cptac:
  description: Simplified and Unified Access to Cancer Proteogenomic Data
  references:
  - citation: Lindgren, C. M., Adams, D. W., Kimball, B., Boekweg, H.,
     Tayler, S., Pugh, S. L., & Payne, S. H. (2021).
     Simplified and Unified Access to Cancer Proteogenomic Data. Journal of proteome research,
     20(4), 1902–1910. https://doi.org/10.1021/acs.jproteome.0c00919
  doi: https://doi.org/10.1021/acs.jproteome.0c00919
  modalities:
    - transcriptomics
    - proteomics
    - mutations
    - copy_number

ctrpv2:
  description: ""
  references:
  - citation: Rees, M. G., Seashore-Ludlow, B., Cheah, J. H., Adams, D. J., Price,
     E. V., Gill, S., Javaid, S., Coletti, M. E., Jones, V. L., Bodycombe, N. E., Soule,
     C. K., Alexander, B., Li, A., Montgomery, P., Kotz, J. D., Hon, C. S., Munoz, B., Liefeld,
      T., Dančík, V., Haber, D. A., … Schreiber, S. L. (2016).
      Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nature chemical biology,
      12(2), 109–116. https://doi.org/10.1038/nchembio.1986
    doi: https://doi.org/10.1038/nchembio.1986
  - citation: Seashore-Ludlow, B., Rees, M. G., Cheah, J. H., Cokol, M., Price, E. V., Coletti,
     M. E., Jones, V., Bodycombe, N. E., Soule, C. K., Gould, J., Alexander, B., Li, A., Montgomery,
     P., Wawer, M. J., Kuru, N., Kotz, J. D., Hon, C. S., Munoz, B., Liefeld, T., Dančík, V., … Schreiber,
      S. L. (2015). Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.
     Cancer discovery, 5(11), 1210–1223. https://doi.org/10.1158/2159-8290.CD-15-0235
    doi: https://doi.org/10.1158/2159-8290.CD-15-0235
  - citation: Basu, A., Bodycombe, N. E., Cheah, J. H., Price, E. V., Liu, K., Schaefer, G. I.,
     Ebright, R. Y., Stewart, M. L., Ito, D., Wang, S., Bracha, A. L., Liefeld, T., Wawer, M.,
     Gilbert, J. C., Wilson, A. J., Stransky, N., Kryukov, G. V., Dancik, V., Barretina, J.,
     Garraway, L. A., … Schreiber, S. L. (2013).
     An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.
     Cell, 154(5), 1151–1161. https://doi.org/10.1016/j.cell.2013.08.003
    doi: https://doi.org/10.1016/j.cell.2013.08.003
  modalities:
    - transcriptomics
    - proteomics
    - mutations
    - copy_number
    - drugs

fimm:
  description: ""
  references:
  - citation: Mpindi, J. P., Yadav, B., Östling, P., Nevedomskaya, E., Tuomela, J.,
      Aittokallio, T., & Wennerberg, K. (2016). Consistency in drug response profiling. Nature, 540(7631), E5–E6.
      https://doi.org/10.1038/nature20171
    doi: https://doi.org/10.1038/nature20171
  - citation: Pemovska, T., Kontro, M., Yadav, B., Edgren, H., Eldfors, S., Szwajda, A., Almusa, H., Bespalov,
     M. M., Ellonen, P., Elonen, E., Gjertsen, B. T., Karjalainen, R., Kulesskiy, E., Lagström, S., Lehto, A., Lepistö, M.,
     Lundán, T., Majumder, M. M., Marti, J. M., Mattila, P., … Wennerberg, K. (2013).
     Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
     Cancer discovery, 3(12), 1416–1429. https://doi.org/10.1158/2159-8290.CD-13-0350
    doi: https://doi.org/10.1158/2159-8290.CD-13-0350
  modalities:
    - transcriptomics
    - proteomics
    - mutations
    - copy_number
    - drugs

gcsi:
  description: ""
  references:
  - citation: Haverty, P. M., Lin, E., Tan, J., Yu, Y., Lam, B., Masoudi, H., Zhang, R.,
      Zhu, X., Ding, L., Swanson, K. D., Watanabe, C., Yang, X., Li, L., Li, M., Liang, H.,
      Lin, W., Lin, Y., Liu, J., Luo, J., Ma, Y., … Liang, H. (2016). Reproducible pharmacogenomic profiling of cancer cell line panels.
      Nature, 533(7603), 333–337. https://doi.org/10.1038/nature17987
    doi: https://doi.org/10.1038/nature17987
  - citation: Klijn, C., Durinck, S., Stawiski, E. W., Haverty, P. M., Jiang, Z., Liu, H.,
     Degenhardt, J., Mayba, O., Gnad, F., Liu, J., Pau, G., Reeder, J., Cao, Y., Mukhyala, K.,
      Selvaraj, S. K., Yu, M., Zynda, G. J., Brauer, M. J., Wu, T. D., Gentleman, R. C., … Zhang, Z. (2015).
      A comprehensive transcriptional portrait of human cancer cell lines. Nature biotechnology, 33(3), 306–312.
      https://doi.org/10.1038/nbt.3080
    doi: https://doi.org/10.1038/nbt.3080
  modalities:
    - transcriptomics
    - proteomics
    - mutations
    - copy_number
    - drugs

gdscv1:
  description: ""
  references:
  - citation: Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau,
     K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., Liu, Q., Iorio, F., Surdez, D.,
     Chen, L., Milano, R. J., Bignell, G. R., Tamura, K., Gaasenbeek, M., Mukherjee, S.,
     Berger, M. F., … McDermott, U. (2012). Systematic identification of genomic markers of drug sensitivity in cancer cells.
     Nature, 483(7391), 570–575. https://doi.org/10.1038/nature11005
    doi: https://doi.org/10.1038/nature11005
  - citation: Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N.,
     Gonçalves, E., Barthorpe, S., Lightfoot, H., Cokelaer, T., Greninger, P., van Dyk, E., Chang, H., de Silva,
      H., Heyn, H., Deng, X., Egan, R. K., Liu, Q., Mironenko, T., … Garnett, M. J. (2016).
      A Landscape of Pharmacogenomic Interactions in Cancer. Cell, 166(3), 740–754. https://doi.org/10.1016/j.cell.2016.06.017
    doi: https://doi.org/10.1016/j.cell.2016.06.017
  - citation: Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D.,
     Smith, J. A., Thompson, I. R., Ramaswamy, S., Futreal, P. A., Haber, D. A., Stratton, M. R., Benes, C., McDermott, U.,
      & Garnett, M. J. (2013). Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
       Nucleic acids research, 41(Database issue), D955–D961. https://doi.org/10.1093/nar/gks1111
    doi: https://doi.org/10.1093/nar/gks1111
  modalities:
    - transcriptomics
    - proteomics
    - mutations
    - copy_number
    - drugs

gdscv2:
  description: ""
  references:
  - citation: Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau,
     K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., Liu, Q., Iorio, F., Surdez, D.,
     Chen, L., Milano, R. J., Bignell, G. R., Tamura, K., Gaasenbeek, M., Mukherjee, S.,
     Berger, M. F., … McDermott, U. (2012). Systematic identification of genomic markers of drug sensitivity in cancer cells.
     Nature, 483(7391), 570–575. https://doi.org/10.1038/nature11005
    doi: https://doi.org/10.1038/nature11005
  - citation: Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N.,
     Gonçalves, E., Barthorpe, S., Lightfoot, H., Cokelaer, T., Greninger, P., van Dyk, E., Chang, H., de Silva,
      H., Heyn, H., Deng, X., Egan, R. K., Liu, Q., Mironenko, T., … Garnett, M. J. (2016).
      A Landscape of Pharmacogenomic Interactions in Cancer. Cell, 166(3), 740–754. https://doi.org/10.1016/j.cell.2016.06.017
    doi: https://doi.org/10.1016/j.cell.2016.06.017
  - citation: Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D.,
     Smith, J. A., Thompson, I. R., Ramaswamy, S., Futreal, P. A., Haber, D. A., Stratton, M. R., Benes, C., McDermott, U.,
      & Garnett, M. J. (2013). Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
       Nucleic acids research, 41(Database issue), D955–D961. https://doi.org/10.1093/nar/gks1111
    doi: https://doi.org/10.1093/nar/gks1111
  modalities:
    - transcriptomics
    - proteomics
    - mutations
    - copy_number
    - drugs

pancpdo:
  description: ""
  references:
  - citation: Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D.,
      Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., Miyabayashi, K., Young, C. M.,
      Patel, H., Shah, M., Sanghvi, R., Goetz, A. B., Lowder, C. Y., Martello, L., Driehuis, E., LeComte, N.,
      … Shen, M. (2018). Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
      Cancer discovery, 8(9), 1112–1129. https://doi.org/10.1158/2159-8290.CD-18-0349
    doi: https://doi.org/10.1158/2159-8290.CD-18-0349
  modalities:
    - transcriptomics
    - mutations
    - copy_number
    - drugs

sarcpdo:
  description: ""
  references:
  - citation: Al Shihabi, A., Tebon, P. J., Nguyen, H. T. L., Chantharasamee, J., Sartini, S.,
      Davarifar, A., Jensen, A. Y., Diaz-Infante, M., Cox, H., Gonzalez, A. E., Norris, S., Sperry, J.,
      Nakashima, J., Tavanaie, N., Winata, H., Fitz-Gibbon, S. T., Yamaguchi, T. N., Jeong, J. H.,
      Dry, S., Singh, A. S., … Soragni, A. (2024). The landscape of drug sensitivity and resistance in sarcoma.
      Cell Stem Cell, 31(10), 1524–1542.e4. https://doi.org/10.1016/j.stem.2024.08.010
    doi: https://doi.org/10.1016/j.stem.2024.08.010
  modalities:
    - transcriptomics
    - mutations
    - drugs

crcpdo:
  description: ""
  references:
  - citation: van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W.,
     van Gorp, J., Taylor-Weiner, A., Kester, L., McLaren-Douglas, A., Blokker, J., Jaksani, S., Bartfeld, S., Volckman,
      R., van Sluis, P., Li, V. S., Seepo, S., Sekhar Pedamallu, C., Cibulskis, K., … Clevers, H. (2015).
      Prospective derivation of a living organoid biobank of colorectal cancer patients.
      Cell, 161(4), 933–945. https://doi.org/10.1016/j.cell.2015.03.053
    doi: https://doi.org/10.1016/j.cell.2015.03.053
  modalities:
    - transcriptomics
    - mutations
    - copy_number
    - drugs

liverpdo:
  description: ""
  references:
  - citation: Ji, S., Feng, L., Fu, Z., Wu, G., Wu, Y., Lin, Y., Lu, D., Song, Y., Cui, P., Yang, Z.,
     Sang, C., Song, G., Cai, S., Li, Y., Lin, H., Zhang, S., Wang, X., Qiu, S., Zhang, X., Hua, G., … Gao, Q. (2023).
      Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Science translational medicine,
       15(706), eadg3358. https://doi.org/10.1126/scitranslmed.adg3358
    doi: https://doi.org/10.1126/scitranslmed.adg3358
  modalities:
    - transcriptomics
    - mutations
    - copy_number
    - drugs

novartispdx:
  description: ""
  references:
  - citation: Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C.,
     Yang, G., Zhang, Y., Balbin, O. A., Barbe, S., Cai, H., Casey, F., Chatterjee, S., Chiang, D. Y., Chuai, S.,
     Cogan, S. M., Collins, S. D., Dammassa, E., … Sellers, W. R. (2015).
     High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
      Nature medicine, 21(11), 1318–1325. https://doi.org/10.1038/nm.3954
    doi: https://doi.org/10.1038/nm.3954
  modalities:
    - transcriptomics
    - mutations
    - copy_number
    - drugs
